Resource Management and Health Notices




3 JULY 2008 NEW ZEALAND GAZETTE, No. 110


Notice

  1. Title and commencement—(1) This notice may be cited as the Resource Management (Approval of Vector Wellington Electricity Network Limited as a Requiring Authority) Notice 2008.

(2) This notice shall come into force on the 28th day after the date of its publication in the New Zealand Gazette.

  1. Interpretation—In this notice, unless the context otherwise requires:

“line function services” has the meaning given to that term by section 2 of the Electricity Act 1992.

2863

  1. Approval as a requiring authority—Vector Wellington Electricity Network Limited is hereby approved as a requiring authority under section 167 of the Resource Management Act 1991, as an electricity distributor for the supply of line function services in the greater Wellington region.

Dated at Wellington this 27th day of June 2008.

HON TREVOR MALLARD, Minister for the Environment.

go4761


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Anastrozole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Goa, India

Product: Diovan
Active Ingredient: Valsartan 320mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland

Product: Gammanorm
Active Ingredient: Normal immunoglobulin 165mg
Dosage Form: Solution for injection
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturer: Octapharma AB, Stockholm, Sweden

Product: Polaramine Colour-Free
Active Ingredient: Dexchlorpheniramine maleate 2mg
Dosage Form: Tablet
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Schering-Plough Laboratories NV, Belgium

Product: Seroquel XR
Active Ingredient: Quetiapine fumarate 230.26mg equivalent to quetiapine free base 200mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Ltd, Silk Macclesfield, Cheshire, United Kingdom

Product: Seroquel XR
Active Ingredient: Quetiapine fumarate 345.38mg equivalent to quetiapine free base 300mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca Pharmaceuticals LP, Newark, Delaware, United States of America
AstraZeneca UK Ltd, Macclesfield, Cheshire, United Kingdom



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 110





✨ LLM interpretation of page content

🏗️ Approval of Vector Wellington Electricity Network Limited as a Requiring Authority (continued from previous page)

🏗️ Infrastructure & Public Works
27 June 2008
Resource Management Act, requiring authority, Vector Wellington Electricity Network Limited
  • HON TREVOR MALLARD, Minister for the Environment

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act, new medicines, distribution consent